The transaction, valued at $1.2 billion, is seen as a positive benchmark for Arcutis, especially considering the promising performance of its product Zoryve in treating psoriasis, atopic dermatitis, ...
This medicated shampoo-conditioner combo contains 3% of the active ingredient and also tackles seborrheic dermatitis and psoriasis, according to the brand. Plus, the provitamin B5 to give your hair ...